Dental Biomaterials Market Size, Share and Growth Outlook, 2026

Dental Biomaterials Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Dental Biomaterials Market size is forecast to increase from $10.13 Billion in 2026 to $18.61 Billion in 2034 at a CAGR of 7.9% between 2026 and 2034.

The Dental Biomaterials market report provides detailed analysis and outlook of Dental Biomaterials segments including By Material Type (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, Metal-Ceramic Biomaterials, Natural Dental Biomaterials ), By Clinical Application (Implantology, Prosthodontics, Orthodontics, Periodontics & Restorative Dentistry ), By End-User (Dental Implant and Prosthetic Manufacturers, Dental Hospitals and Specialty Clinics, Commercial Dental Laboratories, Dental Academies and Research Institutes) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Dental Biomaterials Industry Overview

Regenerative Technologies and Implant Innovations Are Advancing Dental Biomaterials

The dental biomaterials industry is undergoing significant transformation as clinicians increasingly adopt regenerative solutions, advanced bone grafting materials, implant-support technologies, and biologically active treatment approaches. Modern dental biomaterials are designed not only to restore oral function but also to actively support tissue regeneration, bone integration, and long-term implant stability. Growing demand for predictable implant outcomes, minimally invasive procedures, and regenerative dentistry is driving manufacturers to expand their biomaterial portfolios through acquisitions, research investments, and strategic partnerships.

Strategic Acquisitions Strengthen Implant and Regenerative Ecosystems

A major trend within the dental biomaterials industry is the integration of specialized regenerative technologies into comprehensive implant treatment platforms. Nobel Biocare, part of the Envista Holdings Corporation portfolio, completed the acquisition of Versah, a company recognized for its advanced osteotomy and bone densification technologies. The transaction incorporates Versah’s proprietary Osseodensification protocols into Nobel Biocare’s global implant and regenerative biomaterials ecosystem. By integrating advanced site-preparation techniques with implant and regenerative solutions, the combined platform is positioned to support complex implant placement procedures, improve primary implant stability, and enhance clinical outcomes in challenging bone conditions.

Novel Bone Adhesive Technologies Expand Regenerative Treatment Options

Innovation in bone regeneration remains a key focus area within the dental biomaterials industry. RevBio received U.S. Food and Drug Administration clearance to initiate a human clinical trial evaluating its Tetranite regenerative bone adhesive technology for dental applications. Based on a tetracalcium phosphate formulation, the biomaterial is designed to stabilize dental implants immediately following tooth extraction procedures. As healing progresses, the adhesive scaffold gradually resorbs and is replaced by native bone tissue. This regenerative approach reflects the industry's increasing focus on biomaterials capable of supporting immediate implant placement while simultaneously promoting natural bone formation and long-term tissue integration.

Expanded Distribution Networks Improve Access to Dental Solutions

The dental biomaterials industry is also benefiting from broader healthcare distribution strategies that improve access to advanced dental technologies. Midmark Corporation entered into a significant agreement with Vizient, a major healthcare performance improvement organization. The partnership expands the availability of Midmark’s dental equipment and clinical workspace solutions across a large network of hospital systems, academic medical centers, and dental hygiene facilities. Enhanced distribution channels help facilitate the adoption of modern dental technologies and support integrated care environments where advanced biomaterials, implant systems, and clinical equipment work together to improve treatment delivery and patient outcomes.

Dental Biomaterials Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Dental Biomaterials market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona Inc., Straumann Group, Danaher Corporation (Nobel Biocare), Kuraray Noritake Dental Inc., BioHorizons IPH, Inc., Botiss Biomaterials GmbH, Keystone Dental Group, Sunstar Suisse S.A.. The Dental Biomaterials market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Dental Biomaterials industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Dental Biomaterials Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Dental Biomaterials companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Dental Biomaterials markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Dental Biomaterials Market Competitive Benchmarking and Company Analysis

Leading companies in Dental Biomaterials industry include- Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona Inc., Straumann Group, Danaher Corporation (Nobel Biocare), Kuraray Noritake Dental Inc., BioHorizons IPH, Inc., Botiss Biomaterials GmbH, Keystone Dental Group, Sunstar Suisse S.A.. The Dental Biomaterials market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Dental Biomaterials Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Dental Biomaterials market remains one of the strongest-performing segments in the country.
The US Dental Biomaterials Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Dental Biomaterials market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Dental Biomaterials industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Dental Biomaterials markets

Canada's strong Dental Biomaterials sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Dental Biomaterials market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Dental Biomaterials Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Dental Biomaterials market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Dental Biomaterials population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Dental Biomaterials industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Dental Biomaterials market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Dental Biomaterials sales through 2034

France Dental Biomaterials companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Dental Biomaterials Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Dental Biomaterials distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Dental Biomaterials Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Dental Biomaterials market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Dental Biomaterials industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Dental Biomaterials industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Dental Biomaterials Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Dental Biomaterials market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Dental Biomaterials market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Dental Biomaterials Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Dental Biomaterials Market Segmentation

By Material Type
Metallic Biomaterials
Ceramic Biomaterials
Polymeric Biomaterials
Metal-Ceramic Biomaterials
Natural Dental Biomaterials
By Clinical Application
Implantology
Prosthodontics
Orthodontics
Periodontics & Restorative Dentistry
By End-User
Dental Implant and Prosthetic Manufacturers
Dental Hospitals and Specialty Clinics
Commercial Dental Laboratories
Dental Academies and Research Institutes

Top Companies in Dental Biomaterials Industry

Geistlich Pharma AG
Zimmer Biomet Holdings, Inc.
Dentsply Sirona Inc.
Straumann Group
Danaher Corporation (Nobel Biocare)
Kuraray Noritake Dental Inc.
BioHorizons IPH, Inc.
Botiss Biomaterials GmbH
Keystone Dental Group
Sunstar Suisse S.A.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025